EuroPCR Stent Wrap-Up: Biotronik’s Magmaris magnesium stent, Reva’s Fantom Polymer DES, and Elixir’s DESolve
This article was originally published in Clinica
EuroPCR is one of the most important annual conferences for interventional cardiology in the world, always showcasing new catheter-based technologies. The clinical trial presentations at this year’s event, held May 17-20 in Paris, included long-term registry data evaluating established technologies, including Boston Scientific’s Promus Element everolimus-eluting stentand Synergy biosorbable everolimus-eluting stent. But this year’s meeting also included presentations of novel and unproven technologies, especially new approaches to biosorbable stents.